On 18 Nov 2025, Sampre Nutritions opened with a gap down of 4.68%, touching an intraday low of Rs 34.5. The stock’s performance today notably lagged behind its sector, underperforming by 4.59%. Despite the current downward trend, the stock remains above its 50-day, 100-day, and 200-day moving averages, though it trades below the 5-day and 20-day averages, indicating short-term weakness amid longer-term support levels.
This week's revealed pick, a micro-cap from FMCG with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- Target price included
- Early movement detected
- Complete analysis ready
Looking at the broader timeline, Sampre Nutritions has shown mixed performance. Over the past month, the stock declined by 10.07%, contrasting with the Sensex’s positive 0.76% return. However, over three months, the stock surged by 105.82%, significantly outpacing the Sensex’s 4.08% gain. Year-to-date, Sampre Nutritions has delivered a remarkable 116.64% return compared to the Sensex’s 8.26%, reflecting strong longer-term momentum despite recent setbacks.
Over a one-year horizon, the stock posted a 67.84% return, again outperforming the Sensex’s 9.38%. Yet, the three-year view reveals a decline of 13.80%, while the Sensex advanced by 37.18%. Over five and ten years, Sampre Nutritions has recorded substantial gains of 1097.92% and 514.70% respectively, far exceeding the Sensex’s 91.47% and 231.96% returns, underscoring its historical growth trajectory within the FMCG sector.
Is Sampre Nutritions your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- Better alternatives suggested
- Cross-sector comparison
- Portfolio optimization tool
The current market cap grade for Sampre Nutritions stands at 4, reflecting its mid-tier valuation within the FMCG sector. The Mojo Score is 46.0, with a recent adjustment in evaluation on 19 Aug 2025, revising the grade from Strong Sell to Sell. The trigger event on 18 Nov 2025, labelled as "only_sellers," highlights the extreme selling pressure with no buyers present, a rare and concerning market condition.
Investors should note the stark contrast between the stock’s longer-term performance and the immediate distress signals. The absence of buyers today and the consecutive losses suggest heightened caution in the short term. The stock’s underperformance relative to the Sensex and its sector today emphasises the selling momentum dominating trading activity.
In summary, Sampre Nutritions is currently under intense selling pressure, with a clear lack of buying interest. While the stock has demonstrated strong returns over extended periods, the immediate market behaviour signals distress selling and a cautious outlook for the near term. Market participants should closely monitor developments and trading volumes to gauge any potential shift in sentiment.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
